This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
TreeHouse (THS) to Divest Lakeville Facility & Snack Bars Unit
by Zacks Equity Research
TreeHouse Foods' (THS) sale of its Lakeville facility and snack bars business will enable it to better focus on and efficiently direct resources to its private-label snacking and beverage categories.
TreeHouse (THS) Down 7.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
TreeHouse (THS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Can Its Growth Efforts Aid Colgate (CL) Amid Cost Woes?
by Zacks Equity Research
Despite rising raw material costs and adverse currency, Colgate's (CL) robust innovation, pricing efforts and expansion plans are likely to drive growth in the long term.
Solid Market Gains to Aid Keurig Dr Pepper (KDP) Amid Cost Woes
by Zacks Equity Research
Keurig Dr Pepper (KDP) gains from market share growth, continued strength in the cold beverages segment and robust pricing actions. However, rising transportation and labor costs are concerning.
International Flavors (IFF) Misses on Q2 Earnings, Lowers View
by Zacks Equity Research
International Flavors' (IFF) Q2 earnings and sales fall year over year on lower volumes. The company lowers its sales guidance for 2023, anticipating a slow recovery in volumes.
Molson Coors (TAP) Buys Blue Run to Focus on Drinks Beyond Beer
by Zacks Equity Research
Molson Coors' (TAP) latest acquisition of whisky brand Blue Run marks its first spirits acquisition. The move is likely to expand its portfolio beyond beer and aid its premiumization strategy.
Inter Parfums (IPAR) Ups '23 EPS Guidance on Q2 Earnings Beat
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2023 results reflect higher earnings and sales on growth across Europe and U.S.-based operations. Management raises the 2023 earnings view.
Energizer (ENR) Q3 Earnings Miss Estimates, Sales View Down
by Zacks Equity Research
Energizer's (ENR) fiscal third-quarter results reflect a year-over-year decrease in the top and bottom lines. Management lowers its sales outlook for fiscal 2023.
Anheuser-Busch (BUD) Sells 8 Beer & Beverage Brands to Tilray
by Zacks Equity Research
AB InBev (BUD) enters a deal to sell eight beer and beverage brands to Tilray following its Bud Light controversy.
Medifast's (MED) Q2 Earnings Top Estimates, Sales Decline Y/Y
by Zacks Equity Research
Medifast's (MED) second-quarter 2023 results reflect lower sales and earnings on reduced Coach productivity and cost inflation.
TreeHouse Foods (THS) Q2 Earnings Beat Estimates, View Raised
by Zacks Equity Research
TreeHouse Foods' (THS) second-quarter fiscal 2023 results reflect gains from pricing actions to counter cost inflation. Management raises net sales and adjusted EBITDA guidance for fiscal 2023.
Tyson Foods (TSN) Q3 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
Tyson Foods' (TSN) fiscal third-quarter net sales and earnings decline year over year, reflecting challenging market dynamics. Management closes four Chicken facilities in the quarter.
TreeHouse Foods (THS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
TreeHouse (THS) delivered earnings and revenue surprises of 5% and 1.66%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Monster Beverage (MNST) Q2 Profit Meets, Sales Lag Estimates
by Zacks Equity Research
Monster Beverage's (MNST) Q2 results reflect gains from a strong brand performance, innovation, product launches and pricing actions amid currency woes.
Strength in Beer Unit Aids Constellation Brand (STZ) Amid Cost Woes
by Zacks Equity Research
Constellation Brands (STZ) looks well-poised for growth on the back of solid beer unit, strong demand and premiumization strategy. However, higher packaging and raw material costs are woes.
Clorox (CLX) Surpasses Earnings & Sales Estimates in Q4
by Zacks Equity Research
Clorox's (CLX) Q4 results reflect gains from a solid product pipeline, improved pricing, cost savings and strong execution, offset by lower volume and inflation.
Post Holdings (POST) Raises EBITDA View on Q3 Earnings Beat
by Zacks Equity Research
Post Holdings' (POST) third-quarter fiscal 2023 results reflect robust earnings and sales despite cost inflation.
Kellogg's (K) Q2 Earnings & Sales Rise Y/Y, '23 View Moves Up
by Zacks Equity Research
Kellogg's (K) second-quarter 2023 sales and earnings increase year over year on favorable price/mix and solid momentum across snacks. Management raises 2023 view.
Service Corporation (SCI) Q2 Earnings Beat, Sales Rise Y/Y
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2023 earnings fell from the year-ago quarter's level on rising interest costs. Nevertheless, total revenues increased from the year-ago quarter's level.
The Zacks Analyst Blog Highlights Kimberly-Clark, McCormick & Company, J&J Snack, Foods, and TreeHouse Foods
by Zacks Equity Research
Kimberly-Clark, McCormick & Company, J&J Snack, Foods, and TreeHouse Foods are part of the top Zacks Analyst Blog.
Sysco's (SYY) Q4 Earnings Beat Estimates, Sales Advance Y/Y
by Zacks Equity Research
Sysco's (SYY) fourth-quarter fiscal 2023 results reflect higher sales and earnings on volume gains, market share growth, the progress of the Recipe for Growth plan and solid cost management.
Molson Coors (TAP) Q2 Earnings Beat Estimates, Sales Lag
by Zacks Equity Research
Molson Coors' (TAP) Q2 results reflect gains from strength in its core brands, solid pricing and a favorable sales mix, offset by consumer inflationary pressures and a softer beer industry.
Factors Likely to Impact TreeHouse Foods' (THS) Q2 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) Q2 results are likely to reflect resilient growth through efficient pricing and cost-control measures despite supply challenges.
Altria's (MO) Q2 Earnings Meet Estimates, Revenues Down Y/Y
by Zacks Equity Research
Altria's (MO) second-quarter 2023 results benefit from increased pricing, whereas lower shipment volumes remain a downside.
4 Safe Stocks to Buy as Fed Remains Open to More Rate Hikes
by Ritujay Ghosh
It is uncertain how long the Fed will continue with its interest rate hikes. Hence, investing in consumer staple stocks like Kimberly-Clark (KMB), McCormick & Company (MKC), J&J Snack Foods (JJSF) and TreeHouse Foods (THS) is a safe bet.